Literature DB >> 10763759

Cerebral hypothermia for prevention of brain injury following perinatal asphyxia.

A J Gunn1.   

Abstract

The possibility that hypothermia has a therapeutic role during or after resuscitation from severe perinatal asphyxia has been a longstanding focus of research. Early studies using short periods of cooling had limited and contradictory results. We now know that resuscitation can be followed by a "latent" phase, characterized by transient recovery of cerebral energy metabolism, before secondary deterioration occurs with seizures, cytotoxic edema, and cerebral energy failure 6 to 15 hours after birth. Recent experimental studies have shown that moderate cerebral hypothermia initiated as soon as possible in the latent phase, before the onset of secondary injury, and continued for 48 hours or more is associated with potent, long-lasting neuroprotection. These encouraging results must be balanced against the well-known adverse systemic effects of hypothermia. Randomized clinical trials are in progress to test the safety and efficacy of cerebral hypothermia.

Entities:  

Mesh:

Year:  2000        PMID: 10763759     DOI: 10.1097/00008480-200004000-00004

Source DB:  PubMed          Journal:  Curr Opin Pediatr        ISSN: 1040-8703            Impact factor:   2.856


  25 in total

1.  A pilot study of novel biomarkers in neonates with hypoxic-ischemic encephalopathy.

Authors:  Martha Douglas-Escobar; Cui Yang; Jeffrey Bennett; Jonathan Shuster; Douglas Theriaque; Avital Leibovici; David Kays; Tong Zheng; Candace Rossignol; Gerry Shaw; Michael D Weiss
Journal:  Pediatr Res       Date:  2010-12       Impact factor: 3.756

Review 2.  Synergistic neuroprotective therapies with hypothermia.

Authors:  Maria Roberta Cilio; Donna M Ferriero
Journal:  Semin Fetal Neonatal Med       Date:  2010-03-07       Impact factor: 3.926

3.  The Use of Hypothermia Therapy in Traumatic Ischemic / Reperfusional Brain Injury: Review of the Literatures.

Authors:  Shoji Yokobori; Janek Frantzen; Ross Bullock; Shyam Gajavelli; Stephen Burks; Helen Bramlett; W Dalton Dietrich
Journal:  Ther Hypothermia Temp Manag       Date:  2011-12-20       Impact factor: 1.286

4.  Tert-butylhydroquinone post-treatment attenuates neonatal hypoxic-ischemic brain damage in rats.

Authors:  Juan Zhang; Lorelei Donovan Tucker; Yujiao Lu; Luodan Yang; Chongyun Wu; Yong Li; Quanguang Zhang
Journal:  Neurochem Int       Date:  2018-03-09       Impact factor: 3.921

5.  Prenatal Hypoxia Induces Premature Aging Accompanied by Impaired Function of the Glutamatergic System in Rat Hippocampus.

Authors:  Oleg Vetrovoy; Viktor Stratilov; Peter Nimiritsky; Pavel Makarevich; Ekaterina Tyulkova
Journal:  Neurochem Res       Date:  2021-01-02       Impact factor: 3.996

6.  Neuroprotective effect of preoperatively induced mild hypothermia as determined by biomarkers and histopathological estimation in a rat subdural hematoma decompression model.

Authors:  Shoji Yokobori; Shyam Gajavelli; Stefania Mondello; Jixiang Mo-Seaney; Helen M Bramlett; W Dalton Dietrich; M Ross Bullock
Journal:  J Neurosurg       Date:  2012-11-09       Impact factor: 5.115

7.  Hypothermia at 35 °C reduces the time-dependent microglial production of pro-inflammatory and anti-inflammatory factors that mediate neuronal cell death.

Authors:  Tomohiro Matsui; Yusuke Yoshida; Masashi Yanagihara; Hiromi Suenaga
Journal:  Neurocrit Care       Date:  2014-04       Impact factor: 3.210

Review 8.  Hitting a moving target: Basic mechanisms of recovery from acquired developmental brain injury.

Authors:  Christopher C Giza; Bryan Kolb; Neil G Harris; Robert F Asarnow; Mayumi L Prins
Journal:  Dev Neurorehabil       Date:  2009       Impact factor: 2.308

Review 9.  Neonatal encephalopathy: treatment with hypothermia.

Authors:  Seetha Shankaran
Journal:  J Neurotrauma       Date:  2009-03       Impact factor: 5.269

10.  Effect of inborn vs. outborn delivery on neurodevelopmental outcomes in infants with hypoxic-ischemic encephalopathy: secondary analyses of the NICHD whole-body cooling trial.

Authors:  Girija Natarajan; Athina Pappas; Seetha Shankaran; Abbot R Laptook; Michele Walsh; Scott A McDonald; Richard A Ehrenkranz; Jon E Tyson; Ronald N Goldberg; Rebecca Bara; Rosemary D Higgins; Abhik Das; Breda Munoz
Journal:  Pediatr Res       Date:  2012-07-25       Impact factor: 3.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.